It is worth noting that due to the large volume of stromal cell compartment in a human body, the use of anti‐PD‐L1 in cancer therapy would likely require high dosages to saturate PD‐L1 on the surface of stromal cells in vivo. The gene discussed is CD274; the disease is cancer.